Monographie - Topotecan - Stabilis 4.0

Poslední aktualizace :
08/05/2024

Rakovina drog

Topotecan

Injekce

Stabilita roztoků

Stabilita směsí

Faktory ovlivňující stabilitu

Kompatibilita

Způsoby aplikace

Odkazy

Pdf

Chemický vzorec

Obchodní název

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acumil	Mexiko
Camtoop	Mexiko
Cantop	Indie
Hycamtin	äpanÏlsko, Austrálie, Belgie, BrazÌlie, Chile, Dánsko, Egypt, Ekvádor, Finsko, Francie, Irsko, Island, Itálie, Japonsko, Kanada, Kolumbie, Lucembursko, Malajsie, MaÔarsko, NÏmecko, Nizozemsko, Norsko, Polsko, Portugalsko, Rakousko, Saúdská Arábie, Spojené arabské emiráty, Švédsko, Švýcarsko, Turecko, USA, Velká Británie, Venezuela, ÿecko
Oncotecan	Ekvádor, Kolumbie
Potactasol	Argentina, Belgie, NÏmecko, Norsko, Rumunsko
Tekan L	Turecko
Topodria	Kolumbie
Topokebir	Argentina, Peru
Toposec	Peru
Topotecan	äpanÏlsko, Belgie, Kanada, Kolumbie, NÏmecko, Norsko, Peru, Rumunsko, Velká Británie
Topotel	Egypt
Toranex	Mexiko
Tpopoxin	Turecko
Viatopin	MaÔarsko

Odkazy

Injekce

Odkazy : Topotecan

	Typ	Uveřejnění
753	Laboratoř	Topotecan (Topotecan Hospira®) - Summary of Product Characteristics Hospira 2016
823	Noviny	Patel K, Craig SB, McBride MG, Palepu NR. Microbial inhibitory properties and stability of topotecan hydrochloride injection. Am J Health-Syst Pharm 1998 ; 55: 1584-1587.
1026	Noviny	Mayron D, Gennaro AR. Stability and compatibility of topotecan hydrochloride with selected drugs. Am J Health-Syst Pharm 1999 ; 56: 875-881.
1075	Noviny	Craig SB, Bhatt UH, Patel K. Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers. J Pharm Biomed Anal 1997 ; 16: 199-205.
1274	Noviny	Krämer I, Thiesen J. Pharmazeutische aspekte von topotecan-infusionen. TAP Pharmazeutische Zeitung 1997 ; 31: 30-33.
1423	Noviny	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1425	Noviny	Krämer I, Thiesen J. Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices. J Oncol Pharm Practice 1999 ; 5: 75-82.
1662	Noviny	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1953	Noviny	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1976	Noviny	Trissel LA, Xu QA. Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 9, 3: 238-241.

Mentions Légales